Analogs of 5-methylthioribose, a novel class of antiprotozoal agents

M. K. Riscoe, A. J. Ferro, J. H. Fitchen

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Since drug resistance and toxicity limit the use of available antiprotozoal agents, it is important that new drugs be developed as soon as possible. In this study, the method by which several protozoa degrade 5'-methylthioadenosine (MTA) was shown to differ from MTA catabolism in human cells. To exploit this metabolic difference, two analogs of methylthioribose (MTR), an MTA catabolite, were synthesized and found to be cytocidal to Plasmodium falciparum, Giardia lamblia, and Ochromonas malhamensis in vitro. In contrast, these analogs had no effect on cultured mammalian cells. Analogs of MTR represent a potential new class of antiprotozoal drugs.

Original languageEnglish (US)
Pages (from-to)1904-1906
Number of pages3
JournalAntimicrobial agents and chemotherapy
Issue number12
StatePublished - 1988
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Analogs of 5-methylthioribose, a novel class of antiprotozoal agents'. Together they form a unique fingerprint.

Cite this